Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches

References

1. 1.↵
   2. Gillies RJ,
   3. Kinahan PE,
   4. Hricak H

   . Radiomics: images are more than pictures, they are data. Radiology 2016;278:563–77 doi:10.1148/radiol.2015151169 pmid:26579733

   CrossRefPubMed
2. 2.↵
   2. Kumar V,
   3. Gu YH,
   4. Basu S, et al

   . Radiomics: the process and the challenges. Magn Reson Imaging 2012;30:1234–48 doi:10.1016/j.mri.2012.06.010 pmid:22898692

   CrossRefPubMed
3. 3.↵
   2. Ludwig JA,
   3. Weinstein JN

   . Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5:845–56 doi:10.1038/nrc1739 pmid:16239904

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Prior FW,
   3. Clark K,
   4. Commean P, et al

   . TCIA: an information resource to enable open science. In: Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Osaka, Japan. July 3–7, 2013:1282–85
5. 5.↵
   2. Zhou M,
   3. Chaudhury B,
   4. Hall LO, et al

   . Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. J Magn Reson Imaging 2016;46:115–23
6. 6.↵
   2. Aerts HJ,
   3. Velazquez ER,
   4. Leijenaar RTH, et al

   . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006 doi:10.1038/ncomms5006 pmid:24892406

   CrossRefPubMed
7. 7.↵
   2. Gutman DA,
   3. Cooper LA,
   4. Hwang SN, et al

   . MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 2013;267:560–69 doi:10.1148/radiol.13120118 pmid:23392431

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Kotrotsou A,
   3. Zinn PO,
   4. Colen RR

   . Radiomics in brain tumors: an emerging technique for characterization of tumor environment. Magn Reson Imaging Clin North Am 2016;24:719–29 doi:10.1016/j.mric.2016.06.006 pmid:27742112

   CrossRefPubMed
9. 9.↵
   2. Jaffe CC

   . Imaging and genomics: is there a synergy? Radiology 2012;264:329–31 doi:10.1148/radiol.12120871 pmid:22821693

   CrossRefPubMed
10. 10.↵
    2. Michaelis LC,
    3. Ratain MJ

    . Measuring response in a post-RECIST world: from black and white to shades of grey. Nat Rev Cancer 2006;6:409–14 doi:10.1038/nrc1883 pmid:16633367

    CrossRefPubMed
11. 11.↵
    2. Kheifets LI

    . Electric and magnetic field exposure and brain cancer: a review. Bioelectromagnetics 2001;(suppl 5):S120–31 pmid:11170122

    PubMed
12. 12.↵
    2. Gatenby RA,
    3. Grove O,
    4. Gillies RJ

    . Quantitative imaging in cancer evolution and ecology. Radiology 2013;269:8–15 doi:10.1148/radiol.13122697 pmid:24062559

    CrossRefPubMed
13. 13.↵
    1. Drevelegas A

    2. Drevelegas A,
    3. Papanikolaou N

    . Imaging modalities in brain tumors. In: Drevelegas A. Imaging of Brain Tumors with Histological Correlations. Berlin: Springer; 2011:13–33
14. 14.↵
    2. Kickingereder P,
    3. Götz M,
    4. Muschelli J, et al

    . Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin Cancer Res 2016;22:5765–71 doi:10.1158/1078-0432.CCR-16-0702 pmid:27803067

    Abstract/FREE Full Text
15. 15.↵
    2. Itakura H,
    3. Achrol AS,
    4. Mitchell LA, et al

    . Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities. Sci Transl Med 2015;7:303ra138 doi:10.1126/scitranslmed.aaa7582 pmid:26333934

    Abstract/FREE Full Text
16. 16.↵
    2. Zhou M,
    3. Hall L,
    4. Goldgof D, et al

    . Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. Transl Oncol 2014;7:5–13 doi:10.1593/tlo.13730 pmid:24772202

    CrossRefPubMed
17. 17.↵
    2. Tsuchiya K,
    3. Inaoka S,
    4. Mizutani Y, et al

    . Fast fluid-attenuated inversion-recovery MR of intracranial infections. AJNR Am J Neuroradiol 1997;18:909–13 pmid:9159369

    Abstract/FREE Full Text
18. 18.↵
    2. Padhani AR,
    3. Liu G,
    4. Koh DM, et al

    . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–25 doi:10.1593/neo.81328 pmid:19186405

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Bitar R,
    3. Leung G,
    4. Perng R, et al

    . MR pulse sequences: what every radiologist wants to know but is afraid to ask. Radiographics 2006;26:513–37 doi:10.1148/rg.262055063 pmid:16549614

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Lambin P,
    3. Rios-Velazquez E,
    4. Leijenaar R, et al

    . Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441–46 doi:10.1016/j.ejca.2011.11.036 pmid:22257792

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Ambrosini RD,
    3. Wang P,
    4. O'Dell WG

    . Computer-aided detection of metastatic brain tumors using automated three-dimensional template matching. J Magn Reson Imaging 2010;31:85–93 doi:10.1002/jmri.22009 pmid:20027576

    CrossRefPubMed
22. 22.↵
    2. Lowe DG

    . Object recognition from local scale-invariant features. In: Proceedings of the Seventh IEEE International Conference on Computer Vision, Corfu, Greece. September 20–25, 1999:1150–57
23. 23.↵
    1. Ayache N,
    2. Delingette H,
    3. Golland P, et al.

    2. Zikic D,
    3. Glocker B,
    4. Konukoglu E, et al

    . Decision forests for tissue-specific segmentation of high-grade gliomas in multi-channel MR. In: Ayache N, Delingette H, Golland P, et al., eds; Medical Image Computing and Computer-Assisted Intervention–MICCAI 2012. Berlin: Springer; 2012:369–76
24. 24.↵
    2. Reddy KK,
    3. Solmaz B,
    4. Yan P, et al

    . Confidence guided enhancing brain tumor segmentation in multi-parametric MRI. In: Proceedings of the 9th IEEE International Symposium on Biomedical Imaging, Barcelona, Spain. May 2–5, 2012:366–69
25. 25.↵
    2. Zacharaki EI,
    3. Wang S,
    4. Chawla S, et al

    . Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009;62:1609–18 doi:10.1002/mrm.22147 pmid:19859947

    CrossRefPubMed
26. 26.↵
    2. Tuytelaars T,
    3. Mikolajczyk K

    . Local invariant feature detectors: a survey. Foundations and Trends in Computer Graphics and Vision 2008;3:177–280
27. 27.↵
    2. Ojala T,
    3. Pietikäinen M,
    4. Mäenpää T

    . Multiresolution gray-scale and rotation invariant texture classification with local binary patterns. IEEE Transactions on Pattern Analysis and Machine Intelligence 2002;24:971–87 doi:10.1109/TPAMI.2002.1017623

    CrossRefWeb of Science
28. 28.↵
    2. Heikkilä M,
    3. Pietikäinen M,
    4. Schmid C

    . Description of interest regions with local binary patterns. Pattern Recogition 2009;42:425–36 doi:10.1016/j.patcog.2008.08.014

    CrossRef
29. 29.↵
    2. Oliva A,
    3. Torralba A

    . Modeling the shape of the scene: a holistic representation of the spatial envelope. International Journal of Computer Vision 2001;42:145–75 doi:10.1023/A:1011139631724

    CrossRefWeb of Science
30. 30.↵
    2. Kassner A,
    3. Thornhill RE

    . Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol 2010;31:809–16 doi:10.3174/ajnr.A2061 pmid:20395383

    Abstract/FREE Full Text
31. 31.↵
    2. Aerts HJ,
    3. Velazquez ER,
    4. Leijenaar RT, et al

    . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006 doi:10.1038/ncomms5006 pmid:24892406

    CrossRefPubMed
32. 32.↵
    2. Haralick RM,
    3. Shanmugam K,
    4. Dinstein I

    . Textural features for image classification. IEEE Transactions on Systems Man Cybernetics 1973;Smc3:610–21
33. 33.↵
    2. Galloway MM

    . Texture analysis using gray level run lengths. Computer Graphics and Image Processing 1975;4:172–79 doi:10.1016/S0146-664X(75)80008-6

    CrossRef
34. 34.↵
    2. Dalal N,
    3. Triggs B

    . Histograms of oriented gradients for human detection. In: Proceedings of the 2005 IEEE Computer Society Conference on Computer Vision and Pattern Recognition, San Diego, California. June 20–26, 2005:886–93
35. 35.↵
    1. Ayache N,
    2. Delingette H,
    3. Golland P, et al.

    2. Prasanna P,
    3. Tiwari P,
    4. Madabhushi A

    . Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): distinguishing tumor confounders and molecular subtypes on MRI. In: Ayache N, Delingette H, Golland P, et al., eds. Medical Image Computing and Computer-Assisted Intervention–MICCAI 2012. Berlin: Springer; 2012:369–76
36. 36.↵
    2. Leijenaar RT,
    3. Carvalho S,
    4. Velazquez ER, et al

    . Stability of FDG-PET radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol 2013;52:1391–97 doi:10.3109/0284186X.2013.812798 pmid:24047337

    CrossRefPubMed
37. 37.↵
    2. Yun TJ,
    3. Park CK,
    4. Kim TM, et al

    . Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging. Radiology 2015;274:830–40 doi:10.1148/radiol.14132632 pmid:25333475

    CrossRefPubMed
38. 38.↵
    2. Zhou M,
    3. Hall LO,
    4. Goldgof DB, et al

    . Survival time prediction of patients with glioblastoma multiforme tumors using spatial distance measurement. SPIE Proceedings 2013:8670:86702O doi:10.1117/12.2007699

    CrossRef
39. 39.↵
    2. Cao Y,
    3. Tsien CI,
    4. Nagesh V, et al

    . Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. Int J Radiat Oncol Biol Phys 2006;64:876–85 doi:10.1016/j.ijrobp.2005.09.001 pmid:16298499

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Chang PD,
    3. Malone HR,
    4. Bowden SG, et al

    . A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 2017;38:890–98 doi:10.3174/ajnr.A5112 pmid:28255030

    Abstract/FREE Full Text
41. 41.↵
    2. Huo J,
    3. Kim HJ,
    4. Pope WB, et al

    . Histogram-based classification with Gaussian mixture modeling for GBM tumor treatment response using ADC map. SPIE Proceedings 2009:7260:72601Y doi:10.1117/12.812923

    CrossRef
42. 42.↵
    2. Le Bihan D,
    3. Breton E,
    4. Lallemand D, et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07 doi:10.1148/radiology.161.2.3763909 pmid:3763909

    CrossRefPubMedWeb of Science
43. 43.↵
    2. Mazurowski MA,
    3. Desjardins A,
    4. Malof JM

    . Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol 2013;15:1389–94 doi:10.1093/neuonc/nos335 pmid:23396489

    CrossRefPubMed
44. 44.↵
    2. Zinn PO,
    3. Mahajan B,
    4. Majadan B, et al

    . Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 2011;6:e25451 doi:10.1371/journal.pone.0025451 pmid:21998659

    CrossRefPubMed
45. 45.↵
    2. Macyszyn L,
    3. Akbari H,
    4. Pisapia JM, et al

    . Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro Oncol 2016;18:417–25 doi:10.1093/neuonc/nov127 pmid:26188015

    CrossRefPubMed
46. 46.↵
    2. Gevaert O,
    3. Mitchell LA,
    4. Achrol AS, et al

    . Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 2014;273:168–74 doi:10.1148/radiol.14131731 pmid:24827998

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Cruz JA,
    3. Wishart DS

    . Applications of machine learning in cancer prediction and prognosis. Cancer Inform 2007;2:59–77 pmid:19458758

    PubMed
48. 48.↵
    2. Shen D,
    3. Wu G,
    4. Suk HI

    . Deep learning in medical image analysis. Annu Rev Biomed Eng 2017;19:221–48 doi:10.1146/annurev-bioeng-071516-044442 pmid:28301734

    CrossRefPubMed
49. 49.↵
    2. Mitchell T

    . The discipline of machine learning. Carnegie Mellon University, School of Computer Science, Machine Learning Department; 2006. http://docplayer.net/19055685-The-discipline-of-machine-learning.html. Accessed September 26, 2017.
50. 50.↵
    2. Parmar C,
    3. Grossmann P,
    4. Bussink J, et al

    . Machine learning methods for quantitative radiomic biomarkers. Sci Rep 2015;5:13087 doi:10.1038/srep13087 pmid:26278466

    CrossRefPubMed
51. 51.↵
    2. Clark MC,
    3. Hall LO,
    4. Goldgof DB, et al

    . Automatic tumor segmentation using knowledge-based techniques. IEEE Trans Med Imaging 1998;17:187–201 doi:10.1109/42.700731 pmid:9688151

    CrossRefPubMedWeb of Science
52. 52.↵
    2. Menze BH,
    3. Jakab A,
    4. Bauer S, et al

    . The multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Trans Med Imaging 2015;34:1993–2024 doi:10.1109/TMI.2014.2377694 pmid:25494501

    CrossRefPubMed
53. 53.↵
    2. Cruz-Barbosa R,
    3. Vellido A

    . Semi-supervised analysis of human brain tumours from partially labeled MRS information, using manifold learning models. Int J Neural Syst 2011;21:17–29 doi:10.1142/S0129065711002626 pmid:21243728

    CrossRefPubMed
54. 54.↵
    2. LeCun Y,
    3. Bengio Y,
    4. Hinton G

    . Deep learning. Nature 2015;521:436–44 doi:10.1038/nature14539 pmid:26017442

    CrossRefPubMed
55. 55.↵
    2. Szegedy C,
    3. Liu W,
    4. Jia YQ, et al

    . Going deeper with convolutions. In: Proceedings of the 2009 IEEE Conference on Computer Vision and Pattern Recognition, Miami, Florida. June 20–25, 2015:1–9
56. 56.↵
    2. Deng J,
    3. Dong W,
    4. Socher R, et al

    . ImageNet: a large-scale hierarchical image database. In: Proceedings of the 2009 IEEE Conference on Computer Vision and Pattern Recognition, Miami, Florida. June 20–25, 2015:248–55
57. 57.↵
    2. Karpathy A,
    3. Toderici G,
    4. Shetty S, et al

    . Large-scale video classification with convolutional neural networks. In: Proceedings of the 2014 IEEE Conference on Computer Vision and Pattern Recognition, Columbus, Ohio. June 23–28, 2014:1725–32
58. 58.↵
    2. Shen W,
    3. Zhou M,
    4. Yang F, et al

    . Multi-scale convolutional neural networks for lung nodule classification. Inf Process Med Imaging 2015;24:588–99 pmid:26221705

    PubMed
59. 59.↵
    2. Shen W,
    3. Zhou M,
    4. Yang F, et al

    . Multi-crop convolutional neural networks for lung nodule malignancy suspiciousness classification. Pattern Recognition 2017;61:663–73 doi:10.1016/j.patcog.2016.05.029

    CrossRef
60. 60.↵
    2. Setio AA,
    3. Ciompi F,
    4. Litjens G, et al

    . Pulmonary nodule detection in CT images: false positive reduction using multi-view convolutional networks. IEEE Trans Med Imaging 2016;35:1160–69 doi:10.1109/TMI.2016.2536809.69 pmid:26955024

    CrossRefPubMed
61. 61.↵
    2. Pereira S,
    3. Pinto A,
    4. Alves V, et al

    . Brain tumor segmentation using convolutional neural networks in MRI images. IEEE Trans Med Imaging 2016;35:1240–51 doi:10.1109/TMI.2016.2538465 pmid:26960222

    CrossRefPubMed
62. 62.↵
    2. Pope WB,
    3. Sayre J,
    4. Perlina A, et al

    . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466–74 pmid:16286386

    Abstract/FREE Full Text
63. 63.↵
    2. Siu A,
    3. Wind JJ,
    4. Iorgulescu JB, et al

    . Radiation necrosis following treatment of high grade glioma: a review of the literature and current understanding. Acta Neurochir (Wien) 2012;154:191–201; discussion 201 doi:10.1007/s00701-011-1228-6 pmid:22130634

    CrossRefPubMedWeb of Science
64. 64.↵
    2. Hu X,
    3. Wong KK,
    4. Young GS, et al

    . Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging 2011;33:296–305 doi:10.1002/jmri.22432 pmid:21274970

    CrossRefPubMed
65. 65.↵
    2. Chu HH,
    3. Choi SH,
    4. Ryoo I, et al

    . Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging. Radiology 2013;269:831–40 doi:10.1148/radiol.13122024 pmid:23771912

    CrossRefPubMedWeb of Science
66. 66.↵
    2. Chang PD,
    3. Chow DS,
    4. Yang PH, et al

    . Predicting glioblastoma recurrence by early changes in the apparent diffusion coefficient value and signal intensity on FLAIR images. AJR Am J Roentgenol. 2017;208:57–65 doi:10.2214/AJR.16.16234 pmid:27726412

    CrossRefPubMed
67. 67.↵
    2. Ellingson BM,
    3. Cloughesy TF,
    4. Lai A, et al

    . Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 2011;13:401–09 doi:10.1093/neuonc/noq206 pmid:21324937

    CrossRefPubMed
68. 68.↵
    2. Zhou M,
    3. Hall LO,
    4. Goldgof DB, et al

    . Decoding brain cancer dynamics: a quantitative histogram-based approach using temporal MRI. SPIE Proceedings 2015;9414
69. 69.↵
    2. Hygino da Cruz LC Jr.,
    3. Rodriguez I,
    4. Domingues RC, et al

    . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85 doi:10.3174/ajnr.A2397 pmid:21393407

    Abstract/FREE Full Text
70. 70.↵
    2. Tibshirani R

    . Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological) 1996;58:267–88

    Web of Science
71. 71.↵
    2. Gevaert O,
    3. Xu J,
    4. Hoang CD, et al

    . Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data–methods and preliminary results. Radiology 2012;264:387–96 doi:10.1148/radiol.12111607 pmid:22723499

    CrossRefPubMed
72. 72.↵
    2. Shin HC,
    3. Roth HR,
    4. Gao MC, et al

    . Deep convolutional neural networks for computer-aided detection: CNN architectures, dataset characteristics and transfer learning. IEEE Trans Med Imaging 2016;35:1285–98 doi:10.1109/TMI.2016.2528162 pmid:26886976

    CrossRefPubMed
73. 73.↵
    2. Shen W,
    3. Zhou M,
    4. Yang F, et al

    . Learning from experts: developing transferable deep features for patient-level lung cancer prediction. In: Proceedings of the 19th Medical Image Computing and Computer-Assisted Intervention Conference, Athens, Greece. October 17–21, 2016:124–31
74. 74.↵
    2. Mamoshina P,
    3. Vieira A,
    4. Putin E, et al

    . Applications of deep learning in biomedicine. Mol Pharm 2016;13:1445–54 doi:10.1021/acs.molpharmaceut.5b00982 pmid:27007977

    CrossRefPubMed
75. 75.↵
    2. Manyika J,
    3. Chui M,
    4. Brown B, et al

    . Big data: the next frontier for innovation, competition, and productivity. McKinsey Global Institute. 2011. http://www.mckinsey.com/business-functions/digital-mckinsey/our-insights/big-data-the-next-frontier-for-innovation. Accessed September 26, 2017.
76. 76.↵
    2. Bates DW,
    3. Saria S,
    4. Ohno-Machado L, et al

    . Big data in health care: using analytics to identify and manage high-risk and high-cost patients. Health Aff (Millwood) 2014;33:1123–31 doi:10.1377/hlthaff.2014.0041 pmid:25006137

    Abstract/FREE Full Text
77. 77.↵
    Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061–68 doi:10.1038/nature07385 pmid:18772890

    CrossRefPubMedWeb of Science
78. 78.↵
    2. Kalpathy-Cramer J,
    3. Freymann JB,
    4. Kirby JS, et al

    . Quantitative imaging network: data sharing and competitive algorithm validation leveraging The Cancer Imaging Archive. Transl Oncol 2014;7:147–52 doi:10.1593/tlo.13862 pmid:24772218

    CrossRefPubMed
79. 79.↵
    2. Badve C,
    3. Yu A,
    4. Dastmalchian S, et al

    . MR fingerprinting of adult brain tumors: initial experience. AJNR Am J Neuroradiol 2017;38:492–99 doi:10.3174/ajnr.A5035 pmid:28034994

    Abstract/FREE Full Text
80. 80.↵
    2. Aerts HJ

    . The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol 2016;2:1636–42 doi:10.1001/jamaoncol.2016.2631 pmid:27541161

    CrossRefPubMed
81. 81.↵
    2. O'Connor JP,
    3. Aboagye EO,
    4. Adams JE, et al

    . Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 2017;14:169–86 doi:10.1038/nrclinonc.2016 pmid:27725679

    CrossRefPubMed
82. 82.
    2. Ellingson B,
    3. Sahebjam S,
    4. Kim HJ, et al

    . Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma. AJNR Am J Neuroradiol 2014;35:673–79 doi:10.3174/ajnr.A3748 pmid:24136647

    Abstract/FREE Full Text